Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's ...

Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...

Apple’s latest $500 billion pledge could soften tariff blow, Robinhood is latest to see SEC abandon its crypto case, and more ...

European shares advanced on Tuesday, as gains in defence stocks outweighed technology losses spurred by concerns over U.S. chip curbs on China. The pan-European STOXX 600 index rose 0.3% by 0930 GMT.

"For example, in the Krasnoyarsk region. Back in Soviet times, there were plans to build a new hydroelectric power plant and create additional aluminum production facilities," the Russian leader said ...

Makers of copycat versions of Novo Nordisk's (NVO) weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing ...

MOBILE, Ala. (WKRG) — Saad Healthcare — with locations in Mobile and Baldwin counties — has agreed to pay a $3 million ...

MOBILE, Ala. (WKRG) — Saad Healthcare — with locations in Mobile and Baldwin counties — has agreed to pay a $3 million ...

Institutional Class shares of Columbia Overseas Value Fund returned –6.29% for the fourth quarter of 2024. Click here to read ...

Eli Lilly and Company, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Novo Nordisk A/S are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. These ...

Hims & Hers Health shares plunged in extended trading Monday after the online healthcare provider reported falling margins as ...

Investing.com - Hims & Hers said on Monday that it may stop selling legal copies of a popular weight-loss drug made by Denmark's Novo Nordisk (NYSE: NVO), sending shares in the U.